{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T20:17:17Z","timestamp":1786997837078,"version":"build-2736575974"},"reference-count":45,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,3,12]],"date-time":"2026-03-12T00:00:00Z","timestamp":1773273600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100004339","name":"Sanofi","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004339","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100014588","name":"Sanofi Pasteur SA","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100014588","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2026,4]]},"DOI":"10.1016\/j.vaccine.2026.128472","type":"journal-article","created":{"date-parts":[[2026,3,26]],"date-time":"2026-03-26T08:41:49Z","timestamp":1774514509000},"page":"128472","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"special_numbering":"C","title":["Evaluating pertussis vaccine effectiveness in children under 5\u00a0years of age born in France between 2013 and 2019"],"prefix":"10.1016","volume":"79","author":[{"given":"Juan C.","family":"Vargas-Zambrano","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mickael","family":"Arnaud","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ana","family":"Antunes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Khalil","family":"Karzazi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Johanna","family":"Despres","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Regis","family":"Verdier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Florence","family":"Boisnard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jerome","family":"Jund","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cecile","family":"Janssen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Didier","family":"Pinquier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Denis","family":"Macina","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"35","key":"10.1016\/j.vaccine.2026.128472_bb0005","first-page":"433","article-title":"Pertussis vaccines: WHO position paper \u2013 august 2015","volume":"90","author":"World Health Organization","year":"2015","journal-title":"Wkly Epidemiol Rec"},{"key":"10.1016\/j.vaccine.2026.128472_bb0010","series-title":"1997-2000. MMWR Morb Mortal Wkly Rep","first-page":"73","volume":"51(4)","author":"Pertussis--United States","year":"2002"},{"key":"10.1016\/j.vaccine.2026.128472_bb0015","series-title":"Plotkin\u2019s Vaccines (Seventh Edition)","article-title":"Pertussis Vaccines","author":"Edwards","year":"2018"},{"key":"10.1016\/j.vaccine.2026.128472_bb0020","series-title":"Pertussis reported cases and incidence","author":"World Health Organization","year":"2025"},{"issue":"5","key":"10.1016\/j.vaccine.2026.128472_bb0025","doi-asserted-by":"crossref","first-page":"418","DOI":"10.1016\/j.idnow.2021.05.004","article-title":"Pediatric infectious disease group (GPIP) position paper on the immune debt of the COVID-19 pandemic in childhood, how can we fill the immunity gap?","volume":"51","author":"Cohen","year":"2021","journal-title":"Infect Dis Now"},{"key":"10.1016\/j.vaccine.2026.128472_bb0030","series-title":"Increase of pertussis cases in the EU\/EEA","author":"European Centre for Disease Prevention and Control","year":"2025"},{"key":"10.1016\/j.vaccine.2026.128472_bb0035","series-title":"Pertussis Surveillance and Trends","author":"Centers for Disease Control and Prevention","year":"2025"},{"issue":"4","key":"10.1016\/j.vaccine.2026.128472_bb0040","article-title":"Resurgence and atypical patterns of pertussis in China","volume":"88","author":"Mengyang","year":"2024","journal-title":"J Inf Secur"},{"key":"10.1016\/j.vaccine.2026.128472_bb0045","series-title":"Health Brigades Against Whooping Cough Intensify House-to-House Vaccination in Santa Cruz Neighborhoods","author":"Bolivian Ministry of Health and Sports","year":"2025"},{"key":"10.1016\/j.vaccine.2026.128472_bb0050","series-title":"Weekly Bulletin: Communicable Disease Threats Report. Week 12, 17\u201323 March","author":"European Centre for Disease Prevention and Control","year":"2024"},{"key":"10.1016\/j.vaccine.2026.128472_bb0055","series-title":"Situa\u00e7\u00e3o Epidemiol\u00f3gica Brazil","author":"da Sa\u00fade","year":"2023"},{"key":"10.1016\/j.vaccine.2026.128472_bb0060","series-title":"Communicable Diseases Communiqu\u00e9","author":"National Institute for Communicable Diseases (NICD)","year":"2025"},{"key":"10.1016\/j.vaccine.2026.128472_bb0065","series-title":"National Communicable Disease Surveillance Dashboard Australia","author":"National Notifiable Disease Surveillance System","year":"2025"},{"key":"10.1016\/j.vaccine.2026.128472_bb0070","series-title":"Confirmed cases of pertussis in England by month, to end December 2024","author":"GOV.UK","year":"2025"},{"issue":"5","key":"10.1016\/j.vaccine.2026.128472_bb0075","article-title":"Global resurgence of pertussis: a perspective from China","volume":"89","author":"Liu","year":"2024","journal-title":"J Inf Secur"},{"key":"10.1016\/j.vaccine.2026.128472_bb0080","series-title":"Pertussis: (Week 52) Weekly cases of notifiable diseases, United States, U.S. Territories, and Non-U.S. Residents week ending December 28, 2024","author":"Centers for Disease Control and Prevention","year":"2025"},{"issue":"1","key":"10.1016\/j.vaccine.2026.128472_bb0085","doi-asserted-by":"crossref","first-page":"1453","DOI":"10.1186\/s12889-024-18968-y","article-title":"Global burden of pertussis in 204 countries and territories, from 1990 to 2019: results from the global burden of disease study 2019","volume":"24","author":"Nie","year":"2024","journal-title":"BMC Public Health"},{"key":"10.1016\/j.vaccine.2026.128472_bb0090","series-title":"Global Health Observatory data repository. Pertussis: Reported cases by country","author":"World Health Organization","year":"2025"},{"issue":"1","key":"10.1016\/j.vaccine.2026.128472_bb0095","doi-asserted-by":"crossref","DOI":"10.1080\/21645515.2024.2377904","article-title":"Public health management of pertussis in adults: practical challenges and future strategies","volume":"20","author":"MacIntyre","year":"2024","journal-title":"Hum Vaccin Immunother"},{"issue":"17","key":"10.1016\/j.vaccine.2026.128472_bb0100","doi-asserted-by":"crossref","DOI":"10.2807\/1560-7917.ES.2022.27.17.2100515","article-title":"Pertussis surveillance results from a French general practitioner network, France, 2017 to 2020","volume":"27","author":"Debin","year":"2022","journal-title":"Euro Surveill"},{"key":"10.1016\/j.vaccine.2026.128472_bb0105","series-title":"Simplification du calendrier vaccinal","author":"Haut Conseil de la sant\u00e9 Publique","year":"2025"},{"issue":"17","key":"10.1016\/j.vaccine.2026.128472_bb0110","doi-asserted-by":"crossref","first-page":"18","DOI":"10.2807\/1560-7917.ES.2018.23.17.18-00048","article-title":"Extension of French vaccination mandates: from the recommendation of the steering Committee of the Citizen Consultation on vaccination to the law","volume":"23","author":"L\u00e9vy-Bruhl","year":"2018","journal-title":"Euro Surveill"},{"issue":"8","key":"10.1016\/j.vaccine.2026.128472_bb0115","doi-asserted-by":"crossref","DOI":"10.1016\/j.jiph.2025.102801","article-title":"Pertussis hospitalizations in France (2008-2020): a real-world retrospective analysis of incidence and costs based on the French National Health Data System","volume":"18","author":"Vargas-Zambrano","year":"2025","journal-title":"J Infect Public Health"},{"key":"10.1016\/j.vaccine.2026.128472_bb0120","series-title":"High Health Authority recommends vaccination to protect toddlers","author":"Pertussis Outbreak","year":"2025"},{"issue":"2","key":"10.1016\/j.vaccine.2026.128472_bb0125","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1016\/S1473-3099(21)00267-X","article-title":"Effect of change in vaccine schedule on pertussis epidemiology in France: a modelling and serological study","volume":"22","author":"Paireau","year":"2022","journal-title":"Lancet Infect Dis"},{"issue":"6","key":"10.1016\/j.vaccine.2026.128472_bb0130","article-title":"Pediatric ambulatory pertussis epidemiology in France, recent updates","volume":"53","author":"Levy","year":"2023","journal-title":"Infect Dis Now"},{"issue":"31","key":"10.1016\/j.vaccine.2026.128472_bb0135","doi-asserted-by":"crossref","DOI":"10.2807\/1560-7917.ES.2024.29.31.2400459","article-title":"Resurgence of Bordetella pertussis, including one macrolide-resistant isolate, France, 2024","volume":"29","author":"Rodrigues","year":"2024","journal-title":"Euro Surveill"},{"key":"10.1016\/j.vaccine.2026.128472_bb0140","doi-asserted-by":"crossref","DOI":"10.1016\/j.vaccine.2025.126862","article-title":"Clinical characteristics of cases during the 2024 Pertussis epidemic in France, January 2024 to December 2024","volume":"51","author":"Monchausse","year":"2025","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2026.128472_bb0145","series-title":"Coqueluche en France. Bulletin du 22 novembre 2024","author":"Sant\u00e9 Publique France","year":"2025"},{"issue":"7","key":"10.1016\/j.vaccine.2026.128472_bb0150","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1016\/j.medmal.2020.07.004","article-title":"Comparison of whole-cell versus acellular pertussis vaccine effectiveness in school clusters of pertussis, France, 2013","volume":"50","author":"Belchior","year":"2020","journal-title":"Med Mal Infect"},{"issue":"9","key":"10.1016\/j.vaccine.2026.128472_bb0155","doi-asserted-by":"crossref","first-page":"2370","DOI":"10.1016\/j.vaccine.2024.02.090","article-title":"Effectiveness of one and two doses of acellular pertussis vaccines against laboratory-confirmed pertussis requiring hospitalisation in infants: results of the PERTINENT sentinel surveillance system in six EU\/EEA countries, December 2015 - December 2019","volume":"42","author":"Merdrignac","year":"2024","journal-title":"Vaccine"},{"issue":"4","key":"10.1016\/j.vaccine.2026.128472_bb0160","doi-asserted-by":"crossref","first-page":"S149","DOI":"10.1016\/j.respe.2017.05.004","article-title":"Value of a national administrative database to guide public decisions: from the syst\u00e8me national d\u2019information interr\u00e9gimes de l\u2019Assurance Maladie (SNIIRAM) to the syst\u00e8me national des donn\u00e9es de sant\u00e9 (SNDS) in France","volume":"65","author":"Tuppin","year":"2017","journal-title":"Rev Epidemiol Sante Publique"},{"issue":"6","key":"10.1016\/j.vaccine.2026.128472_bb0165","doi-asserted-by":"crossref","first-page":"659","DOI":"10.1016\/j.therap.2024.05.003","article-title":"Use of the French National Health Data System (SNDS) in pharmacoepidemiology: a systematic review in its maturation phase","volume":"79","author":"Maillard","year":"2024","journal-title":"Therapie"},{"issue":"1","key":"10.1016\/j.vaccine.2026.128472_bb0170","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1002\/pds.3891","article-title":"Guidelines for good pharmacoepidemiology practice (GPP)","volume":"25","author":"Public Policy Committee ISoP","year":"2016","journal-title":"Pharmacoepidemiol Drug Saf"},{"issue":"4","key":"10.1016\/j.vaccine.2026.128472_bb0175","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.0010045","article-title":"Bordetella pertussis, the causative agent of whooping cough, evolved from a distinct, human-associated lineage of B. Bronchiseptica","volume":"1","author":"Diavatopoulos","year":"2005","journal-title":"PLoS Pathog"},{"key":"10.1016\/j.vaccine.2026.128472_bb0180","series-title":"Anatomical Therapeutic Chemical (ATC) Classification","author":"World Health Organization","year":"2025"},{"issue":"49","key":"10.1016\/j.vaccine.2026.128472_bb0185","doi-asserted-by":"crossref","first-page":"5856","DOI":"10.1016\/j.vaccine.2013.09.052","article-title":"Validation of the French national health insurance information system as a tool in vaccine safety assessment: application to febrile convulsions after pediatric measles\/mumps\/rubella immunization","volume":"31","author":"Hanf","year":"2013","journal-title":"Vaccine"},{"issue":"23","key":"10.1016\/j.vaccine.2026.128472_bb0190","doi-asserted-by":"crossref","first-page":"3120","DOI":"10.1016\/j.vaccine.2021.04.032","article-title":"Pertussis vaccine effectiveness and duration of protection - a systematic review and meta-analysis","volume":"39","author":"Wilkinson","year":"2021","journal-title":"Vaccine"},{"issue":"2","key":"10.1016\/j.vaccine.2026.128472_bb0195","doi-asserted-by":"crossref","first-page":"456","DOI":"10.1086\/514064","article-title":"Effectiveness of the pertussis vaccination program as determined by use of the screening method: United States, 1992-1994","volume":"176","author":"Guris","year":"1997","journal-title":"J Infect Dis"},{"issue":"27\u201328","key":"10.1016\/j.vaccine.2026.128472_bb0200","doi-asserted-by":"crossref","first-page":"3530","DOI":"10.1016\/j.vaccine.2004.03.046","article-title":"Impact of routine vaccination with a pertussis toxoid vaccine in Denmark","volume":"22","author":"Hviid","year":"2004","journal-title":"Vaccine"},{"issue":"23","key":"10.1016\/j.vaccine.2026.128472_bb0205","doi-asserted-by":"crossref","first-page":"3035","DOI":"10.1016\/j.vaccine.2009.03.041","article-title":"Effectiveness of two pertussis vaccines in preterm Danish children","volume":"27","author":"Hviid","year":"2009","journal-title":"Vaccine"},{"issue":"2","key":"10.1016\/j.vaccine.2026.128472_bb0210","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1086\/341027","article-title":"Effectiveness of acellular pertussis vaccine assessed by hospital-based active surveillance in Germany","volume":"35","author":"Juretzko","year":"2002","journal-title":"Clin Infect Dis"},{"issue":"6","key":"10.1016\/j.vaccine.2026.128472_bb0215","doi-asserted-by":"crossref","first-page":"334","DOI":"10.5694\/mja13.11069","article-title":"Acellular pertussis vaccine effectiveness for children during the 2009-2010 pertussis epidemic in Queensland","volume":"200","author":"Sheridan","year":"2014","journal-title":"Med J Aust"},{"issue":"6","key":"10.1016\/j.vaccine.2026.128472_bb0220","doi-asserted-by":"crossref","first-page":"1444","DOI":"10.1016\/j.vaccine.2019.11.069","article-title":"Dose-dependent effectiveness of acellular pertussis vaccine in infants: a population-based case-control study","volume":"38","author":"Mack","year":"2020","journal-title":"Vaccine"},{"issue":"1","key":"10.1016\/j.vaccine.2026.128472_bb0225","doi-asserted-by":"crossref","DOI":"10.1038\/s41467-024-44943-7","article-title":"Maternal pertussis immunization and the blunting of routine vaccine effectiveness: a meta-analysis and modeling study","volume":"15","author":"Briga","year":"2024","journal-title":"Nat Commun"}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X2600280X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X2600280X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,6,12]],"date-time":"2026-06-12T23:50:58Z","timestamp":1781308258000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X2600280X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4]]},"references-count":45,"alternative-id":["S0264410X2600280X"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2026.128472","relation":{},"ISSN":["0264-410X"],"issn-type":[{"value":"0264-410X","type":"print"}],"subject":[],"published":{"date-parts":[[2026,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Evaluating pertussis vaccine effectiveness in children under 5\u00a0years of age born in France between 2013 and 2019","name":"articletitle","label":"Article Title"},{"value":"Vaccine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.vaccine.2026.128472","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Authors. Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"128472"}}